Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: metabolic diseases

NIHR and Diabetes UK invest nearly £3m to prevent and treat diabetes distress

NIHR and Diabetes UK invest nearly £3m to prevent and treat diabetes distress
p p Read More

Almost 50% of adults living with type 1 diabetes experience high levels of diabetes distress

July 15, 2024 D-Stress, diabetes distress, Diabetes UK, metabolic diseases, National Institute for Health and Care Research, News, type 1 diabetes

Boehringer Ingelheim and Ochre Bio partner on liver disease in deal worth over $1bn

Chronic liver disease and associated cirrhosis account for one million deaths every year

April 23, 2024 Boehringer Ingelheim, chronic liver disease, metabolic diseases, metabolic dysfunction-associated steatohepatitis, News, Ochre Bio
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy